dormix 12.5 mg tabletti, kalvopäällysteinen
orion corporation - doxylamine hydrogen succinate - tabletti, kalvopäällysteinen - 12.5 mg - doksylamiini
dormix 25 mg tabletti, kalvopäällysteinen
orion corporation - doxylamine hydrogen succinate - tabletti, kalvopäällysteinen - 25 mg - doksylamiini
bonjesta 20 mg / 20 mg säädellysti vapauttava tabletti
exeltis healthcare s.l. - pyridoxine hydrochloride, doxylamine hydrogen succinate - säädellysti vapauttava tabletti - 20 mg / 20 mg - doksylamiini
xonvea 10 mg / 10 mg enterotabletti
campuspharma ab - pyridoxine hydrochloride, doxylamine hydrogen succinate - enterotabletti - 10 mg / 10 mg - doksylamiini
zenti 12.5 mg jauhe
meda otc - doxylamini hydrogenosuccinas - jauhe - 12.5 mg - doksylamiini
zenti 25 mg jauhe
meda otc - doxylamini hydrogenosuccinas - jauhe - 25 mg - doksylamiini
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - muut hermoston huumeet - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
dropizol 10 mg/ml tipat, liuos
pharmanovia a/s - opium tincture standardised - tipat, liuos - 10 mg/ml - opium
wakix
bioprojet pharma - pitolisant - narkolepsia - muut hermoston huumeet - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.